Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v8-EN | Version v3-FR | |
---|---|---|
Language | English | French |
Date Updated | 2017-04-08 | 2017-03-15 |
Drug Identification Number | 02244622 | 02244622 |
Brand name | MILRINONE LACTATE INJECTION | MILRINONE LACTATE INJECTION |
Common or Proper name | Milrinone Lactate Injection 1 mg/mL SD Vial 20 mL | Milrinone Lactate Injection 1 mg/mL SD Vial 20 mL |
Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
Ingredients | MILRINONE | MILRINONE |
Strength(s) | 1.0MG | 1.0MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 20mL | 20mL |
ATC code | C01CE | C01CE |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-03-20 | 2017-03-20 |
Actual start date | ||
Estimated end date | 2017-04-12 | |
Actual end date | 2017-04-07 | |
Shortage status | Resolved | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Available at all locations Friday April 7th. | 10 mL vial available for substitution. |
Health Canada comments |